Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences
Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS). | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Multiple Sclerosis, Secondary Progressive, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Recruiting | Phase 2 / Phase 3 | 2023-07-28 | NCT05961644 |